Investigating the choriocapillaris and choroidal vasculature with new optical coherence tomography technologies

Progress in Retinal and Eye Research

Volumn 52, Issue , 2016, Pages 130-155

  Ferrara, Daniela ^a   Waheed, Nadia K ^a   Duker, Jay S ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Choriocapillaris; Choroid; En face; Optical coherence tomography; Optical coherence tomography angiography

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGING; ANGIOGRAPHY; ARTIFACT; BRUCH MEMBRANE; CENTRAL SEROUS RETINOPATHY; CHOROID; CHOROID CAPILLARY LAYER; CHOROID DISEASE; CHOROID VASCULARIZATION; CHOROIDAL THICKNESS; DIABETIC CHOROIDOPATHY; GEOGRAPHIC ATROPHY; HISTOLOGY; HUMAN; IMAGE PROCESSING; INNERVATION; MYOPIA; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY; PACHYCHOROID SPECTRUM DISORDER; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; REVIEW; SCLERA; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY; VISUAL IMPAIRMENT; VISUAL SYSTEM PARAMETERS; ANIMAL; DIAGNOSTIC IMAGING;

ANIMALS; CHOROID; CHOROID DISEASES; HUMANS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84951310122     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2015.10.002     Document Type: Review

References (288)

1. Adatia F.A., Luong M., Munro M., Tufail A. The other CNVM: a review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factors agents. Surv. Ophthalmol. 2015, 60:204-215.
2. Adhi M., Duker J.S. Optical coherence tomography - current and future applications. Curr. Opin. Ophthalmol. 2013, 24:213-221.
3. Adhi M., Alwassia A.A., Duker J.S. Analysis of choroidal thickness in eyes treated with focal laser photocoagulation using SD-OCT. Can. J. Ophthalmol. 2013, 48:535-538.
4. Adhi M., Brewer E., Waheed N.K., Duker J.S. Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography. JAMA Ophthalmol. 2013, 131:1267-1274.
5. Adhi M., Liu J.J., Qavi A.H., Grulkowski I., Fujimoto J.G., Duker J.S. Enhanced visualization of the choroido-scleral interface using swept-source OCT. Ophthalmic Surg. Lasers Imaging Retina 2013, 44:S40-S42.
6. Adhi M., Liu J.J., Qavi A.H., Grulkowski I., Lu C.D., Mohler K.J., Ferrara D., Kraus M.F., Baumal C.R., Witkin A.J., Waheed N.K., Hornegger J., Fujimoto J.G., Duker J.S. Choroidal analysis in healthy eyes using swept-spirce optical coherence tomography compared to spectral domain optical coherence tomography. Am. J. Ophthalmol. 2014, 157:1272-1281.
7. Adhi M., Ferrara D., Mullins R., Baumal C.R., Mohler K.J., Ktauss M.F., Liu J., Badaro E., Alasil T., Hornegger J., Fujimoto J.G., Duker J.S., Waheed N.K. Characterization of choroidal layers in normal aging eyes using enface swept-source optical coherence tomography. PLoS One 2015, 10:e0133080.
8. Agawa T., Miura M., Ikuno Y., Makita S., Fabritius T., Iwasaki T., Goto H., Nishida K., Yasuno Y. Choroidal thickness measurement in healthy Japanese subjects by three-dimensional high-penetration optical coherence tomography. Graefes Arch. Clin. Exp. Ophthalmol. 2011, 249:1485-1492.
9. Alasil T., Ferrara D., Adhi M., Brewer E., Kraus M.F., Baumal C.R., Hornegger J., Fujimoto J.G., Witkin A.J., Reichel E., Duker J.S., Waheed N.K. En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography. Am. J. Ophthalmol. 2015, 159:634-643.
10. Alm A., Bill A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and someother tissues. Exp. Eye Res. 1973, 15:15-19.
11. Anderson D.H., Mullins R.F., Hageman G.S., Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 2002, 134:411-431.
12. Anderson D.H., Radeke M.J., Gallo N.B., Chapin E.A., Johnson P.T., Curletti C.R., Hancox L.S., Hu J., Ebright J.N., Malek G., Hauser M.A., Rickman C.B., Bok D., Hageman G.S., Johnson L.V. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited 2010, 29:95-112.
13. Barteselli G., Chhablani J., El-Emam S., Wang H., Chuang J., Kosak I., Cheng L., Bartsch D.U., Freeman W.R. Choroidal volume variations with age, axial length, and sex in healthy subjects: a three-dimensional analysis. Ophthalmology 2012, 119:2572-2578.
14. Bearelly S., Chau F.Y., Koreishi A., Stinnett S.S., Izatt J.A., Toth C.A. Spectral domain optical coherence tomography imaging of geographic atrophy margins. Ophthalmology 2009, 116:1762-1769.
15. Benavente-Perez A., Hosking S.L., Logan N.S., Bansal D. Reproducibility-repeatability of choroidal thickness calculation using optical coherence tomography. Optom. Vis. Sci. 2010, 87:867-872.
16. Bergamnson J. The ophthalmic innervation of the uvea in monkeys. Exp. Eye Res. 1977, 24:225.
17. Bhutto I., Lutty G. Understanding age-related macular degeneration (AMD): relatioships between the photoreceptor/retinal pigment epithelium/Bruch membrane/choriocapillaris complex. Mol. Asp. Med. 2012, 33(4):295-317.
18. Bindewald A., Schmitz-Valckenberg S., Jorzik J.J., Dolar-Szczasny J., Sieber H., Keilhauer C., Wei nberger A.W., Dithmar S., Pauleikhoff D., Mansmann U., Wolf S., Holz F.G. Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Br. J. Ophthalmol. 2005, 89:874-878.
19. Bird A.C. Therapeutic targets in age-related macular disease. J. Clin. Invest 2010, 120:3033-3041.
20. Blaauwgeers H.G., Holtkamp G.M., Rutten H., Witmer A.N., Koolwijik P., Partanen T.A., Alitalo K., Kroon M.E., Kijlstra A., van Hinsbergh V.W., Schlingemann R.O. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localized vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am. J. Pathol. 1999, 155(2):421-428.
21. Bonini Filho M.A., de Carlo T.E., Ferrara D., Adhi M., Baumal C.R., Witkin A.J., Reichel E., Duker J.S. Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography. JAMA Ophthalmol. 2015 May, [Epub ahead of print]. 10.1001/jamaophthalmol.2015.1320.
22. Bora N.S., Gobleman C.L., Atkinson J.P., Pepose J.S., Kaplan H.J. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol. Vis. Sci. 1993, 34:3579-3584.
23. Branchini L., Regatieri C.V., Flores-Moreno I., Baumann B., Fujimoto J.G., Duker J.S. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology 2012, 119:119-123.
24. Branchini L.A., Adhi M., Regatieri C.V., Nandakumar N., Liu J.J., Laver N., Fujimoto J.G., Duker J.S. Analysis of choroidal morphologic features and vasculature in healthy eyes using spectral-domain optical coherence tomography. Ophthalmology 2013, 120:1901-1908.
25. Brandl C., Helbig H., Gamulescu M.A. Choroidal thickness measurements during central serous chorioretinopathy treatment. Int. Ophthalmol. 2014, 34:7-13.
26. Braun R.D., Dewhirst M.W., Hatchell D.L. Quantification of erythrocyte flow in the choroid of the albino rat. Am. J. Physiol. 1997, 272(3 Pt 2):H1444-H1453.
27. Bron A.J., Tripathi R.C., Tripathi B.J. Wolff's Anatomy of the Eye and Orbit 1997, 736. Chapman and Hall Medical, London. eighth ed.
28. Brown J.S., Flitcroft D.I., Ying G.S., Francis E.L., Schmid G.F., Quinn G.E., Stone R.A. In vivo human choroidal thickness measurements: evidence for diurnal fluctuations. Invest Ophthalmol. Vis. Sci. 2009, 50:5-12.
29. Buschini E., Fea A.M., Lavia C.A., Nassisi M., Pignata G., Zola M., Grignolo F.M. Recent developments in the management of dry-age related macular degeneration. Clin. Ophthalmol. 2015, 9:563-574.
30. Caillaux V., Gaucher D., Gualino V., Massin P., Tadayoni R., Gaudric A. Morphologic characterization of dome-shaped macula in myopic eyes with serous macular detachment. Am. J. Ophthalmol. 2013, 156:958-967.
31. Carrai P., Pichi F., Bonsignore F., Ciardella A.P., Nucci P. Wide-field spectral domain-optical coherence tomography in central serous chorioretinopathy. Int. Ophthalmol. 2015, 35:167-171.
32. Chakraborty R., Read S.A., Collins M.J. Diurnal variations in axial length, choroidal thickness, intraocular pressure, and ocular biometrics. Invest Ophthalmol. Vis. Sci. 2011, 52:5121-5134.
33. Chassine T., Villain M., Hamel C.P., Daien V. How can we prevent myopia progression?. Eur. J. Ophthalmol. 2015, 25:280-285.
34. Chen Q., Fan W., Niu S., Shi J., Shen H., Yuan S. Automated choroid segmentation based on gradual intensity distance in HD-OCT images. Opt. Express 2015, 23:8974-8994.
35. Chinn S.R., Swanson E.A., Fujimoto J.G. Optical coherence tomography using a frequency-tunable optical source. Opt. Lett. 1997, 22:340-342.
36. Choi W., Mohler K.J., Potsaid B., Lu C.D., Liu J.J., Jayaraman V., Cable A.E., Duker J.S., Huber R., Fujimoto J.G. Choriocapillaris and choroidal microvasculature imaging with ultrahigh speed OCT angiography. PLoS One 2013, 8:e81499.
37. Choma M., Sarunic M., Yang C., et al. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt. Express 2003, 49:4679-4687.
38. Chung S.E., Kang S.W., Lee J.H., Kim Y.T. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 2011, 118:840-845.
39. Cicinelli M.V., Pierro L., Gagliardi M., Bandello F. Optical coherence tomography and pathological myopia: an update of the literature. Int. Ophthalmol 2015, [Epub ahead of print]. 10.1007/s10792-015-0118-y.
40. Copete S., Flores-Moreno I., Montero J.A., Duker J.S., Ruiz-Moreno J.M. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br. J. Ophthalmol. 2014, 98:334-338.
41. Coscas F., Coscas G., Souied E. Polypoidal choroidal vasculopathy and macroaneurysm: respective roles of scanning laser ophthalmoscopy-indocyanine green angiography and optical coherence tomography. Eur. J. Ophthalmol. 2011, 21:331-335.
42. Coscas F., Puche N., Coscas G., Srour M., Francais C., Glacet-Bernard A., Querques G., Souied E.H. Comparison of macular choroidal thickness in adult onset foveomacular Vitelliform dystrophy and age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2014, 55:64-69.
43. Coscas G., Lupidi M., Coscas F., Benjelloun F., Zerbib J., Dirani A., Semoun O., Souied E.H. Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2015, 56:3187-3195.
44. Cousins S.W., Espinosa-Heidmann D.G., Alexandridou A., Sall J., Dubovy S., Csaky K. The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp. Eye Res. 2002, 75:543-553.
45. Cousins S.W., Marin-Castano M.E., Espinosa-Heidmann D.G., Alexandridou A., Striker L., Elliot S. Female gender, estrogen loss, and sub-RPE deposit formation in aged mice. Invest Ophthalmol. Vis. Sci. 2003, 44:1221-1229.
46. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14682-14687.
47. Danesh H., Kafieh R., Rabbani H., Hajizadeh F. Segmentation of choroidal boundary in enhanced depth imaging OCTs using a multiresolution texture based modeling in graph cuts. Comput. Math. Methods Med. 2014, 2014:479268.
48. Dansingani K.K., Balaratnasingam C., Klufas M.A., Sarraf D., Freund K.B. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am. J. Ophthalmol. 2015, pii: S0002-9394(15)00534-6, [Epub ahead of print]. 10.1016/j.ajo.2015.08.028.
49. Dansingani K.K., Balaratnasingam C., Naysan J., Freund K.B. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina 2015, [Epub ahead of print].
50. de Carlo T.E., Bonini Filho M.A., Chin A.T., Adhi M., Ferrara D., Baumal C.R., Witkin A.J., Reichel E., Duker J.S., Waheed N.K. Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology 2015, 122:1228-1238.
51. Del Priori L.V., Geng L., Tezel T.H., Kaplan H.J. Extracellular matrix ligands promote RPE attachment to inner Bruch membrane. Curr. Eye Res. 2002, 25(2):79-89.
52. Dithmar S., Curcio C.A., Le N.A., Brown S., Grossniklaus H.E. Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest Ophthalmol. Vis. Sci. 2000, 41:2035-2042.
53. Dithmar S., Sharara N.A., Curcio C.A., Le N.A., Zhang Y., Brown S., Grossniklaus H.E. Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch. Ophthalmol. 2001, 119:1643-1649.
54. Duan L., Hong Y.J., Yasuno Y. Automated segmentation and characterization of choroidal vessels in high-penetration optical coherence tomography. Opt. Express 2013, 21:15787-15808.
55. El Matri L., Bouladi M., Chebil A., Kort F., Bouraoui R., Larqueche L., Mghaieth F. Choroidal thickness measured in highly myopic eyes using SD-OCT. Ophthalmic Surg. Lasers Imaging 2012, 43:S38-S43.
56. Ellabban A.A., Tsujikawa A., Matsumoto A., Ogino K., Hangai M., Ooto S., Yamashiro K., Akiba M., Yoshimura N. Macular choroidal thickness and volume in eyes with angioid streaks measured by swept source optical coherence tomography. Am. J. Ophthalmol. 2012, 153:1133-1143.
57. Esmaeelpour M., Povazay B., Hermann B., Hofer B., Kajic V., Kapoor K., Sheen N.J., North R.V., Drexler W. Three-dimensional 1060-nm OCT: choroidal thickness maps in normal subjects and imporved posterior segment visualization in cataract patients. Invest Ophthalmol. Vis. Sci. 2010, 51:5260-5266.
58. Esmaeelpour M., Povazay B., Hermann B., Hofer B., Kajic V., Hale S.L., North R.V., Drexler W., Sheen N.J. Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography. Invest Ophthalmol. Vis. Sci. 2011, 52:5311-5316.
59. Esmaeelpour M., Asnari-Shahrezaei S., Glittenberg C., Nemetz S., Kraus M.F., Hornegger J., Fujimoto J.G., Drexler W., Binder S. Choroid, Haller's, and Sattler's layer thickness in intermediate age-related macular degeneration with and without fellow neovascular eyes. Invest Ophthalmol. Vis. Sci. 2014, 55:5074-5080.
60. Evans J.R. Risk factors for age-related macular degeneration. Prog. Retin Eye Res. 2001, 20:227-253.
61. Feeney L., Hogan M. Electron microscopy of the human choroid. Am. J. Ophthalmol. 1961, 51:1057-1087.
62. Feeney-Burns L., Burns R.P., Gao C.L. Age-related macular changes in humans over 90 years old. Am. J. Ophthalmol. 1990, 109:265-278.
63. Fein J.G., Branchini L.A., Manjunath V., Regatieri C.V., Fujimoto J.G., Duker J.S. Analysis of short-term change in subfoveal choroidal thickness in eyes with age-related macular degeneration using optical coherence tomography. Ophthalmic Surg. Lasers Imaging Retina 2014, 45:32-37.
64. Ferrara D., Seddon J.M. Phenotypic characterization of complement factor H R1210C rare genetic variant in age-related macular degeneration. JAMA Ophthalmol. 2015, 133:785-791.
65. Ferrara D., Mohler K.J., Waheed N., Adhi M., Liu J.J., Grulkowski I., Kraus M.F., Baumal C., Hornegger J., Fujimoto J.G., Duker J.S. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. Ophthalmology 2014, 121:719-726.
66. Fingler J., Scwartz D., Yang C., Fraser S.E. Mobility and transverse flow visualization using phase variance contrast with spectral domain optical coherence tomography. Opt. Express 2007, 15:12636-12653.
67. Fixler D., Duadi H., Ankri R., Zalevsky Z. Determination of coherence length in biological tissues. Lasers Surg. Med. 2011, 43:339-343.
68. Fleckenstein M., Schmitz-Valckenberg S., Adrion C., Kramer I., Eter N., Helb H.M., Brinkmann C.K., Charbel Issa P., Mansmann U., Holz F.G. Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2010, 51:3846-3852.
69. Fleckenstein M., Schmitz-Valckenberg S., Martens C., Kosanetzky S., Brinkmann C.K., Hageman G.S., Holz F.G. Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy. Invest Ophthalmol. Vis. Sci. 2011, 52:3761-3766.
70. Flores-Moreno I., Arias-Barquet L., Rubio-Caso M.J., Ruiz-Moreno J.M., Duker J.S., Caminal J.M. En face swept-source optical coherence tomography in neovascular age-related macular degeneration. Br. J. Ophthalmol. 2015, 99:1260-1267.
71. Forte R., Querques G., Querques L., Leveziel N., Benhamou N., Souied E.H. Multimodal evaluation of foveal sparing in patients with geographic atrophy due to age-related macular degeneration. Retina 2013, 33:482-489.
72. Freund K.B., Zweifel S.A., Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration?. Retina 2010, 30:1333-1349.
73. Friedman E. Choroidal blood flow. Pressure-flow relationships. Arch. Ophthalmol. 1970, 83:95-99.
74. Friedman E., Chandra S.R. Choroidal blood flow III: effects of oxygen and carbon dioxide. Arch. Ophthalmol. 1972, 87:70-71.
75. Friedman E., Kopald H.H., Smith T.R. Retinal and choroidal blood flow determined with krypton-85 anesthetized animals. Invest Ophthalmol. Vis. Sci. 1964, 3:539-547.
76. Fryczkowski A.W. Anatomical and functional choroidal lobuli. Int. Ophthalmol. 1994, 18:131-141.
77. Fryczowski A.W., Sato S.E., Hodes B.L. Changes in the diabetic choroidal vasculature: scanning electron microscopy findings. Ann. Ophthalmol. 1988, 20:299-305.
78. Fryczowski A.W., Hodes B.L., Walker J. Diabetic choroidal and iris vasculature scanning electron microscopy findings. Int. Ophthalmol. 1989, 13:269-279.
79. Fujimoto J.G., Drexler W. Introduction to optical coherence tomography. Optical Coherence Tomography Technology and Application 2009, 1-45. Springer, Heidelberg. J.G. Fujimoto, W. Drexler (Eds.).
80. Fujiwara T., Imamura Y., Margolis R., et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am. J. Ophthalmol. 2009, 148:445-450.
81. Gallego-Pinazo R., Dolz-Marco R., Gomez-Ulla F., Mrejen S., Freund K.B. Pachychoroid disease of the macula. Med. Hypothesis Discov. Innov. Ophthalmol. 2014, 3:111-115.
82. Garg A., Oll M., Yzer S., Chang S., Barile G.R., Merriam J.C., Tsang S.H., Bearelly S. Reticular pseudodrusen in early age-related macular degeneration are associated with choroidal thinning. Invest Ophthalmol. Vis. Sci. 2013, 54:7075-7081.
83. Gass J.D. Pathogenesis of disciform detachment of the neuroepithelium. Am. J. Ophthalmol. 1967, 63(Suppl. l.):1-139.
84. Gaucher D., Erginay A., Lecleire-Collet A., Haouchine B., Puech M., Cohen S.Y., Massin P., Gaudric A. Dome-shaped macula in eyes with myopic posterior staphyloma. Am. J. Ophthalmol. 2008, 145:909-914.
85. Gerendas B.S., Waldstein S.M., Simader C., Deak G., Hajnajeeb B., Zhang L., Boqunovic H., Abramoff M.D., Kundi M., Sonka M., Schmidt-Erfurth U. Three-dimensional automated choroidal volume assessed on standard spectral-domain optical coherence tomography and correlation with the level of diabetic macular edema. Am. J. Ophthalmol. 2014, 158:1039-1048.
86. Gohil R., Sivaprasad S., Han L.T., Mathew R., Kiousis G., Yang Y. Myopic foveoschisis: a clinical review. Eye (Lond) 2015, 29:593-601.
87. Gong J., Sagiv O., Cai H., Tsang S.H., Del Priori L.V. Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal pigment epithelial progenitors. Exp. Eye Res. 2008, 86(6):957-965.
88. Gotoh N., Yamada R., Nakanishi H., Saito M., Iida T., Matsuda F., Yoshimura N. Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population. Clin. Exp. Ophthalmol. 2008, 36:437-442.
89. Guyer D.R., Yannuzzi L.A., Slakter J.S., Sorenson J.A., Ho A., Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch. Ophthalmol. 1994, 112:1057-1062.
90. Hageman G.S., Mullins R.F. Molecular composition of drusen as related to substructural phenotype. Mol. Vis. 1999, 5:28.
91. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch membrane interface in aging and age-related macular degeneration. Prog. Retin Eye Res. 2001, 20:705-732.
92. Hamzah F., Shinojima A., Mori R., Yuzawa M. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy. BMC Ophthalmol. 2014, 14:145.
93. Hass P., Esmaeelpour M., Ansari-Shahrezaei S., Drexler W., Binder S. Choroidal thickness in patients with reticular pseudodrusen using 3D 1060-nm OCT maps. Invest Ophthalmol. Vis. Sci. 2014, 55:2674-2681.
94. Hayreh S.S. The ophthalmic artery: III. Branches. Br. J. Ophthalmol. 1962, 46:212-247.
95. Hayreh S.S. Segmental nature of the choroidal vasculature. Br. J. Ophthalmol. 1975, 59:631-648.
96. Hayreh S.S. In vivo choroidal circulation and its watershed zones. Eye (Lond) 1990, 4(Pt 2):273-289.
97. Hayreh S.S. The blood supply of the optic nerve head and the evaluation of it - myth and reality. Prog. Ret Eye Res. 2001, 20:563-569.
98. Hidayat A.A., Fine B.S. Diabetic choroidopathy. Light and electron microscopic obervations of seven cases. Ophthalmology 1985, 92:512-522.
99. Hirata M., Tsujikawa A., Matsumoto A., et al. Macular choroidal thickness and volume in normal eyes measured by swept-source optical coherence tomography. Invest Ophthalmol. Vis. Sci. 2011, 52:4971-4978.
100. Ho J., Branchini L., Regatieri C., Krishnan C., Fujimoto J.G., Duker J.S. Analysis of normal peripapillary choroidal thickness via spectral domain optical coherence tomography. Ophthalmology 2011, 118:2001-2007.
101. Ho M., Liu D.T., Chan V.C., Lam D.S. Choroidal thickness measurement in myopic eyes by enhanced depth optical coherence tomography. Ophthalmology 2013, 120:1909-1914.
102. Hogan M. Ultrastructure of the choroid. Its role in the pathogenesis of chorioretinal diseases. Trans. Pac. Coast Oto Ophthalmol. Soc. 1961, 42:61-87.
103. Holz F.G., Bindewald-Wittich A., Fleckenstein M., Dreyhaupt J., Scholl H.P., Schmitz-Valckenberg S. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am. J. Ophthalmol. 2007, 143:463-472. FAM-Study Group.
104. Houssier M., Raoul W., Lavalette S., Keller N., Guillonneaux X., Baragatti B., Jonet L., Jeanny J.C., Behar-Cohen F., Coceani F., Scherman D., Lachapelle P., Ong H., Chemtob S., Sennlaub F. CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents. PLoS Med. 2008, 5:e39.
105. Hu Z., Wu X., Ouyang Y., Sadda S.R. Semiautomated segmentation of the choroid in spectral-domain optical coherence tomography volume scans. Invest Ophthalmol. Vis. Sci. 2013, 54:1722-1729.
106. Huang Y., Zhang Q., Wang R.K. Efficient method to suppress artifacts caused by tissue hyper-reflections in optical micronagiography of retina in vivo. Biomed. Opt. Express 2015, 6:1195-1208.
107. Ida H., Ishibashi K., Reiser K., Hjelmeland L.M., Handa J.T. Ultrastructural aging of the RPE-Bruch's membrane-choriocapillaris complex in the D-galactose-treated mouse. Invest Ophthalmol. Vis. Sci. 2004, 45:2348-2354.
108. Iida T., Kishi S., Hagimura N., Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999, 19:508-512.
109. Iida T., Spaide R.F., Haas A., Yannuzzi L.A., Jampol L.M., Lesser R.L. Leopard-spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch. Ophthalmol. 2002, 120:37-42.
110. Ikuno Y., Tano Y. Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. Invest Ophthalmol. Vis. Sci. 2009, 50:3876-3880.
111. Ikuno Y., Kawaguchi K., Nouchi T., Yasuno Y. Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol. Vis. Sci. 2010, 51:2173-2176.
112. Ikuno Y., Maruko I., Yasuno Y., Miura M., Sekiryu T., Nishida K., Iida T. Reproducibility of retinal and choroidal thickness measurements in enhanced depth imaging and high-penetration optical coherence tomography. Invest Ophthalmol. Vis. Sci. 2011, 52:5536-5540.
113. Ikuno Y., Fujimoto S., Jo Y., Asai T., Nishida K. Choroidal thinning in high myopia measured by optical coherence tomography. Clin. Ophthalmol. 2013, 7:889-893.
114. Imamura Y., Fujiwara T., Margolis R., Spaide R.F. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009, 29:1469-1473.
115. Imamura Y., Engelbert M., Iida T., Freund K.B., Yannuzzi L.A. Polypoidal choroidal vasculopathy: a review. Surv. Ophthalmol. 2010, 55:501-515.
116. Jha P., Bora P.S., Bora N.S. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol. Immunol. 2007, 44:3901-3908.
117. Jia Y., Tan O., Tokayer J., Potsaid B., Wang Y., Liu J.J., Kraus M.F., Subhash H., Fujimoto J.G., Hornegger J., Huang D. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt. Express 2012, 20(4):4710-4725.
118. Jirarattanasopa P., Ooto S., Nakata I., Tsujikawa A., Yamashiro K., Oishi A., Yoshimura N. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol. Vis. Sci. 2012, 53:3663-3672.
119. Jirarattanasopa P., Ooto S., Tsujikawa A., Yamashiro K., Hangai M., Hirata M., Matsumoto A., Yoshimura N. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. Ophthalmology 2012, 119:1666-1678.
120. Johnson L.V., Leitner W.P., Staples M.K., Anderson D.H. Complement activation and inflammatory processes in drusen formation and age-related macular degeneration. Exp. Eye Res. 2001, 73:887-896.
121. Kajic V., Esmaeelpour M., Povazay B., Marshall D., Rosin P.L., Drexler W. Automated choroidal segmentation of 1060 nm OCT in helathy and pathologic eyes using a statistical model. Biomed. Opt. Express 2012, 3:86-103.
122. Kajic V., Esmaeelpour M., Glittenberg C., Kraus M.F., Honegger J., Othara R., Binder S., Fujimoto J.G., Drexler W. Automated three-dimensional choroidal vessel segmentation of 3D 1060 nm OCT retinal data. Biomed. Opt. Express 2013, 4:134-150.
123. Kameda T., Tsujikawa A., Otani A., Sasahara M., Gotoh N., Tamura H., Yoshimura N. Polypoidal choroidal vasculopathy examined with en face optical coherence tomography. Clin. Exp. Ophthalmol. 2007, 35:596-601.
124. Kanagasingam Y., Bhuiyan A., Abramoff M.D., Smith R.T., Goldschmidt L., Wong T.Y. Progress on retinal image analysis for age related macular degeneration. Prog. Retin Eye Res. 2014, 38:20-42.
125. Kang H.M., Kwon H.J., Yi J.H., Lee C.S., Lee S.C. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration. Am. J. Ophthalmol. 2014, 157:1013-1021.
126. Keane P.A., de Salvo G., Sim D.A., Goverdhan S., Agrawal R., Tufail A. Strategies for improving detection and diagnosis of neovascular age-related macular degeneration. Clin. Ophthalmol. 2015, 9:353-366.
127. Kiel J.W., van Heuven W.A. Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol. Vis. Sci. 1995, 36:579-585.
128. Kim D.Y., Fingler J., Werner J.S., Schwartz D.M., Fraser S.E., Zawadzki R.J. In vivo volumetric imaging of human retinal circulation with phase-variance optical coherence tomography. Biomed. Opt. Express 2011, 2(6):1504-1513.
129. Kim S.W., Oh J., Kwon S.S., Yoo J., Huh K. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. Retina 2011, 31:1904-1911.
130. Kim J.H., Kang S.W., Kim T.H., Kim S.J., Ahn A.J. Structure of polypoidal choroidal vasculopathy studied by colocalization between tomographic and angiographic lesions. Am. J. Ophthalmol. 2013, 156:974-980.
131. Kim J.T., Lee D.H., Joe S.G., Kim J.G., Yoon Y.H. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol. Vis. Sci. 2013, 54:3378-3384.
132. Klein R., Klein B.E., Tomany S.C., Meuer S.M., Huang G.H. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 2002, 109:1767-1779.
133. Kliffen M., Lutgens E., Daemen M.J., de Muinck E.D., Mooy C.M., de Jong P.T. The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br. J. Ophthalmol. 2000, 84:1415-1419.
134. Knight O.J., Chang R.T., Feuer W.J., et al. Comparison of retinal nerve fiber layer measurements using time domain and spectral domain optical coherence tomography. Ophthalmology 2009, 116:1271-1277.
135. Koizumi H., Yamagishi T., Yamazaki T., Kawasaki R., Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2011, 249:1123-1128.
136. Koizumi H., Yamagishi T., Yamazaki T., Kinoshita S. Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability. Am. J. Ophthalmol. 2013, 155:305-313.
137. Koizumi H., Kano M., Yamamoto A., Saito M., Maruko I., Kawasaki R., Sekiryu T., Okada A.A., Iida T. Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration. Am. J. Ophthalmol. 2015, 159:627-633.
138. Kraus M.F., Liu J.J., Schottenhammi J., Chen C.L., Budai A., Branchini L., Ko T., Ishikawa H., Wollstein G., Schuman J., Duker J.S., Fujimoto J.G., Hornegger J. Qunatitative 3D-OCT motion correction with tilt and illumination correction, robust similarity measure and regularization. Biomed. Opt. Express 2014, 5:2591-2631.
139. Kuehlewein L., Bansal M., Lenis T.L., Iafe N.A., Sadda S.R., Bonini Filho M.A., De Carlo T.E., Waheed N.K., Duker J.S., Sarraf D. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am. J. Ophthalmol. 2015, 160:739-748.
140. Kuehlewein L., Tepelus T.C., An L., Durbin M.K., Srinivas S., Sadda S.R. Noninvasive visualization and analysis of the human parafoveal capillary network using swept source OCT optical microangiography. Invest Ophthalmol. Vis. Sci. 2015, 56:3984-3988.
141. Kuroiwa S., Tateiwa H., Hisatomi T., Ishibashi T., Yoshimura N. Pathologic features of surgically excised polypoidal choroidal vasculopathy membranes. Clin. Exp. Ophthalmol. 2004, 32:297-302.
142. Lafaut B.A., Aisenbrey S., Van den Broecke C., Bartz-Schmidt K.U., Heimann K. Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000, 20:650-654.
143. Lam C.S., Goldschmidt E., Edwards M.H. Prevalence of myopia in local and international schools in Hong Kong. Optim. Vis. Sci. 2004, 81:317-322.
144. Lee C.S., Woo S.J., Kim Y.K., Hwang D.J., Kang H.M., Kim H., Lee S.C. Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation. Ophthalmology 2014, 121:1029-1035.
145. Lehmann M., Wolff B., Vasseur V., Martinet V., Manasseh N., Sahel J.A., Mauget-Faysse M. Retinal and choroidal changes observed with 'En face' enhanced-depth imaging OCT in central serous chorioretinopathy. Br. J. Ophthalmol. 2013, 97:1181-1186.
146. Lehmann M., Bousquet E., Beydoun T., Behar-Cohen F. Pachychoroid: an inherited condition?. Retina 2015, 35:10-16.
147. Leitgeb R.A., Werkmeister R.M., Blatter C., Schmetterer L. Doppler optical coherence tomography. Prog. Retin Eye Res. 2014, 41:26-43.
148. Levinson R.D., Brezin A., Rothova A., et al. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus reference. Am. J. Ophthalmol. 2006, 141:185-187.
149. Li X.Q., Larsen M., Munch I.C. Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish university students. Invest Ophthalmol. Vis. Sci. 2011, 52:8438-8441.
150. Liew G., Quin G., Gillies M., Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin. Exp. Ophthalmol. 2013, 41:201-214.
151. Lim F.P., Loh B.K., Cheung C.M., Lim L.S., Chan C.M., Wong D.W. Evaluation of focal choroidal excavation in the macula using swept-source optical coherence tomography. Eye (Lond) 2014, 28:1088-1094.
152. Lima L.H., Schubert C., Ferrara D.C., et al. Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy. Ophthalmology 2010, 117:1567-1570.
153. Lindner M., Bezatis A., Czauderna J., Becker E., Brinkmann C.K., Schmitz-Valckenberg S., Fimmer R., Holz F.G., Fleckenstein M. Choroidal thickness in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2015, 56:875-882.
154. Lutjen-Drecoll E. Choroidal innervation in primate eyes. Exp. Eye Res. 2006, 82:357-361.
155. Lutty G., Grunwald J., Majji A.B., Uyama M., Yoneya S. Changes in choriocapilarris and retinal pigment epithelium in age-related macular degeneration. Mol. Vis. 1999, 5:35.
156. MacCumber M.W., Dastgheib K., Bressler N.M., Chan C.C., Harris M., Fine S., Green W.R. Clinico-pathologic correlation of the multiple recurrent serosanguineous retinal pigment epithelial detachments syndrome. Retina 1994, 14:143-152.
157. Majji A.B., Cao J., Chang K.Y., Hayashi A., Aggarwal S., Grebe R.R., de Juan E. Age-related retinal pigment epithelium and Bruch's membrane degeneration in senescence-accelerated mouse. Invest Ophthalmol. Vis. Sci. 2000, 41:3936-3942.
158. Manjunath V., Fujimoto J.G., Duker J.S. Cirrus HD-OCT high definition imaging is another tool available for visualization of the choroid and provides agreement with the finding that choroidal thickness is increased in central serous chorioretinopathy in comparison to normal eyes. Retina 2010, 30:1320-1321.
159. Manjunath V., Taha M., Fujimoto J.G., Duker J.S. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am. J. Ophthalmol. 2010, 150:325-329.e1.
160. Manjunath V., Goren J., Fujimoto J.G., Duker J.S. Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Am. J. Ophthalmol. 2011, 152:663-668.
161. Margolis R., Mukkamala S.K., Jampol L.M., Spaide R.F., Ober M.D., Sorenson J.A., Gentile R.C., Miller J.A., Sherman J., Freund K.B. The expanded spectrum of focal choroidal excavation. Arch. Ophthalmol. 2011, 129:1320-1325.
162. Margolis R., Spaide R.F. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am. J. Ophthalmol. 2009, 147:811-815.
163. Marshall G.E., Konstas A.G., Reid G.G., Edwards J.G., Lee W.R. Collagens in the aged human macula. Graefes Arch. Clin. Exp. Ophthalmol. 1994, 232:133-140.
164. Maruko I., Iida T., Sugano Y., Ojima A., Ogasawara M., Spaide R.F. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 2010, 117:1792-1799.
165. Maruko I., Iida T., Sugano Y., et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 2011, 1603-1608.
166. Matsuo Y., Sakamoto T., Yamashite T., Tomita M., Shirasawa M., Terasaki H. Comparisons of choroidal thickness of normal eyes obtained by two different spectral-domain OCT instruments and one swept-source OCT instrument. Invest Ophthalmol. Vis. Sci. 2013, 54:7630-7636.
167. McCourt E.A., Cadena B.C., Barnett C.J., et al. Measurement of subfoveal choroidal thickness using spectral domain optical coherence tomography. Ophthalmic Surg. Lasers Imaging 2010, 41(Suppl. l.):S28-S33.
168. McLeod D.S., Lutty G.A. High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol. Vis. Sci. 1994, 35:3799-3811.
169. McLeod D.S., Lefer D.J., Merges C., Lutty G.A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am. J. Pathol. 1995, 147:642-653.
170. McLeod D.S., Grebe R., Bhutto I., Merges C., Baba T., Lutty G.A. Relatioship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2009, 50:4982-4991.
171. Miceli M.V., Newsome D.A., Tate D.J., Sarphie T.G. Pathologic changes in the retinal pigment epithelium and Bruch's membrane of fat-fed atherogenic mice. Curr. Eye Res. 2000, 20:8-16.
172. Michalewska Z., Michalewski J., Nawrocka Z., Dulczewska-Cichecka K., Nawrocki J. Suprachoroidal layer and suprachoroidal space delineating the outer margin of the choroid in swept-source optical coherence tomography. Retina 2015, 35:244-249.
173. Motaghiannezam R., Schwartz D.M., Fraser S.E. In vivo human choroidal vascular pattern visualization using high-speed swept-source optical coherence tomography at 1060nm. Invest Ophthalmol. Vis. Sci. 2012, 53:2337-2348.
174. Moult E., Choi W., Waheed N.K., Adhi M., Lee B., Lu C.D., Jayaraman V., Potsaid B., Rosenfeld P.J., Duker J.S., Fujimoto J.G. Ultrahigh-speed swept-source OCT angiography in exudative AMD. Ophthalmic Surg. Lasers Imaging Retina 2014, 45:496-505.
175. Mrejen S., Spaide R.F. Optical coherence tomography: imaging of the choroid and beyond. Surv. Ophthalmol. 2013, 58:387-429.
176. Mrejen S., Spaide R.F. The relationship between pseudodrusen and choroidal thickness 2014, 34:1560-1566.
177. Mullins R.F., Johnson M.N., Faidley E.A., Skeie J.M., Huang J. Choriocapillaris vascular droptout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2011, 52:1606-1612.
178. Mutti D.O., Hayes J.R., Mitchell G.L., Jones L.A., Moeschberger M.L., Cotter S.A., Kleinstein R.N., Manny R.E., Twelker J.D., Zadnik K. Fefractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol. Vis. Sci. 2007, 48:2510-2519. CLEERE Study Group.
179. Nagaoka T., Kitaya N., Sugawara R., Yokota H., Mori F., Hikichi T., Fujio N., Yoshida A. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br. J. Ophthalmol. 2004, 88:1060-1063.
180. Nakashizuka H., Mitsumata M., Okisaka S., Shimada H., Kawamura A., Mori R., Yuzawa M. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol. Vis. Sci. 2008, 49:4729-4737.
181. Nishida Y., Fujiwara T., Imamura Y., Lima L.H., Kurosaka D., Spaide R.F. Choroidal thickness and visual acuity in highly myopic eyes. Retina 2012, 32:1229-1236.
182. Nishide T., Hayakawa N., Nakanishi M., Ishii M., Okasaki S., Kimura I., Shibuya E., Mizuki N. Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy. Graefes Arch. Clin. Exp. Ophthalmol. 2013, 251:2415-2420.
183. Ojima Y., Hangai M., Sakamoto A., Tsujikawa A., Otani A., Tamura H., Yoshimura N. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 2009, 29:52-59.
184. Okubo A., Sameshima M., Uemura A., Kanda S., Ohba N. Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br. J. Ophthalmol. 2002, 86:1093-1098.
185. Olsen T.S., Wassef N.F., Olsen H.S., Hansen H.E. Ultrastructure of the kidney in acute interstitial nephritis. Ultrastruct. Pathol. 1986, 10:1-16.
186. Olsen S., Burdick J.F., Keown P.A., Wallace A.C., Racusen L.C., Solez K. Primary acute renal failure ("acute tubular necrosis") in the transplanted kidney: morphology and pathogenesis. Med. Baltim. 1989, 68:173-187.
187. Olver J.M. Functional anatomy of the choroidal circulation: methyl methacrylate casting of human choroid. Eye 1990, 4:262-272.
188. Olver J.M., McCartney A.C. Orbital and ocular micro-vascular corrosion casting in man. Eye (Lond) 1989, 3:588-596.
189. Ooto S., Hangai M., Tomidokoro A., Saito H., Araie M., Otani T., Kishi S., Matsushita K., Maeda N., Shirakashi M., Abe H., Ohkubo S., Sugiyama K., Iwase A., Yoshimura N. Effects of age, sex, and axial length on the three-dimensional profile of normal macular layer structures. Invest Ophthalmol. Vis. Sci. 2011, 52:8769-8779.
190. Ooto S., Hangai M., Yoshimura N. Effects of sex and age on the normal retinal and choroidal structures on optical coherence tomography. Curr. Eye Res. 2015, 40:213-225.
191. Pang C.E., Freund K.B. Pachychoroid pigment epitheliopathy may masquerade as acute retinal pigment epithelitis. Invest Ophthalmol. Vis. Sci. 2014, 55:5252.
192. Pang C.E., Freund K.B. Pachychoroid neovasculopathy. Retina 2015, 35:1-9.
193. Pang C.E., Shah V.P., Sarraf D., Freund K.B. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy. Am. J. Ophthalmol. 2014, 158:362-371.
194. Park K.A., Oh S.Y. An optical coherence tomography-based analysis of choroidal morphologic features and choroidal vascular diameter in childrens and adults. Am. J. Ophthalmol. 2014, 158:716-723.
195. Patel S.R., Berezovsky D.E., McCarey B.E., Zarnitsyn V., Edelhauser H.F., Prausnitz M.R. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol. Vis. Sci. 2012, 53:4433-4441.
196. Pearce W., Hsu J., Yeh S. Advances in drug delivery to the posterior segment. Curr. Opin. Ophthalmol. 2015, 26:233-239.
197. Penfold P.L., Madigan M.C., Gillies M.C., Provis J.M. Immunological and aetiological aspects of macular degeneration. Prog. Retin Eye Res. 2001, 20:385-414.
198. Pikuleva I.A., Curcio C.A. Cholesterol in the retina: the best is yet to come. Prog. Retin Eye Res. 2014, 41:64-89.
199. Pitcher J.D., Witkin A.J., DeCroos F.C., Ho A.C. A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study. Br. J. Ophthalmol. 2015, 99:848-852.
200. Poccolino F.C., Borgia L., Zinicola E., Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye (Lond) 1995, 9(Pt 3):324-332.
201. Polak K., Luksch A., Berisha F., Fuchsjaeger-Mayrl G., Dallinger S., Schmetterer L. Altered nitric oxide system in patients with open-angle glaucoma. Arch. Ophthalmol. 2007, 125:494-498.
202. Polska E., Simader C., Weigert G., Doelemeyer A., Kolodjaschna J., Scharmann O., Schmetterer L. Regulation of choroidal blood flow during combined changes in intraocular pressure and arterial blood pressure. Invest Ophthalmol. Vis. Sci. 2007, 48:3768-3774.
203. Potsaid B., Baumann B., Huang D,Barry S., Cable A.E., Schuman J.S., Duker J.S., Fujimoto J.G. Ultrahigh speed 1050nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second. Opt. Express 2010, 18:20029-20048.
204. Prunte C., Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am. J. Ophthalmol. 1996, 121:26-34.
205. Querques G., Lattanzio R., Querques L., Del Turco C., Forte R., Pierro L., Souied E.H., Bandello F. Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol. Vis. Sci. 2012, 53:6017-6024.
206. Querques G., Querques L., Forte R., Massamba N., Coscas F., Souied E.H. Invest Ophthalmol. Vis. Sci. 2012, 53:1258-1263.
207. Rakoczy P.E., Zhang D., Robertson T., Barnett N.L., Papadimitriou J., Constable I.J., Lai C.M. Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am. J. Pathol. 2002, 161:1515-1524.
208. Ramrattan R.S., van der Schaft T.L., Mooy C.M., de Bruijn W.C., Mulder P.G., de Jong P.T. Morphometric analysis of Bruch membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol. Vis. Sci. 1994, 35:2857-2864.
209. Rayess N., Rahimy E., Ying G.S., Bagheri N., Ho A.C., Regillo C.D., Vander J.F., Hsu J. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am. J. Ophthalmol. 2015, 159:85-91.
210. Razavi S., Souied E.H., Cavallero E., Weber M., Querques G. Assessment of choroidal topographic changes by swept-source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy. Am. J. Ophthalmol. 2014, 157:852-860.
211. Read S.A., Collins M.J., Sander B.P. Human optical axial length and defocus. Invest Ophthalmol. Vis. Sci. 2010, 51:6262-6269.
212. Regatieri C.V., Branchini L., Carmody L., Fujimoto J.G., Duker J.S. Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina 2012, 32:563-568.
213. Riva C.E., Titze P., Hero M., Movaffaghy A., Petrig B.L. Choroidal blood flow during isometric exercises. Invest Ophthalmol. Vis. Sci. 1997, 38:2338-2343.
214. Riva C.E., Titze P., Hero M., Petrig B.L. Effect of acute decreases of perfusion pressure on choroidal blood flow in humans. Invest Ophthalmol. Vis. Sci. 1997, 38:1752-1760.
215. Rosa R.H., Thomas M.A., Green W.R. Clinicopathologic correlation of submacular membranectomy with retention of good vision in patients with age-related macular degeneration. Arch. Ophthalmol. 1996, 114:480-487.
216. Rosa R.H., Davis J.L., Eifrig C.G., Tex T. Clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy. Arch. Ophthalmol. 2002, 120:502-508.
217. Ruiz-Medrano J., Flores-Moreno I., Pena-Garcia P., Montero J.A., Duker J.S., Ruiz-Moreno J.M. Macular choroidal thickness profile in a healthy population measured by swept-source optical coherence tomography. Invest Ophthalmol. Vis. Sci. 2014, 55:3532-3542.
218. Ruskell G. Facial parasympathetic innervation of the choroidal blood vessels in monkeys. Exp. Eye Res. 1971, 12:166.
219. Saint-Geniez M., Kurihara T., Sekiyama E., et al. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc. Natl. Acad. Sci. USA 2009, 106:18751-18756.
220. Saito M., Iida T., Nagayama D. Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy. Retina 2008, 28:459-464.
221. Sanchez-Cano A., Orduna E., Segura F., Lopez C., Cuenca N., Abecia E., Pinilla I. Choroidal thickness and volume in healthy young white adults and the relationships between them and axial length, ammetrophy and sex. Am. J. Ophthalmol. 2014, 158:574-583.
222. Sarks S.H. Ageing and degeneration in the macular region: a clinic-pathological study. Br. J. Ophthalmol. 1976, 60:324-341.
223. Sasahara M., Tsujikawa A., Musashi K., Gotoh N., Otani A., Mandai M., Yoshimura N. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am. J. Ophthalmol. 2006, 142:601-607.
224. Saw S.M., Gazzard G., Shih-Yen E.C., Chua W.H. Myopia and associated pathological complications. Ophthalmic Physiol. Opt. 2005, 25:381-391.
225. Sayegh R.G., Simader C., Scheschy U., Montuoro A., Kiss C., Sacu S., Kreil D.P., Prunte C., Schmidt-Erfurth U. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. Ophthalmology 2011, 118:1844-1851.
226. Schin J.W., Shin Y.U., Lee B.R. Choroidal thickness and volume mapping by a six radial scan protocol on spectral-domain optical coherence tomography. Ophthalmology 2012, 119:1017-1023.
227. Schmidt-Erfurth U., Waldstein S.M. A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog. Retin Eye Res. Aug 2015, 22. pii: S1350-9462(15)00067-1, [Epub ahead of print]. 10.1016/j.preteyeres.2015.07.007.
228. Schmitz-Valckenberg S., Bindewald-Wittich A., Dolar-Szczasny J., Dreyhaupt J., Wolf S., Scholl H.P., Holz F.G. Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol. Vis. Sci. 2006, 47:2648-2654. Fundus Autofluorescence in Age-Related Macular Degeneration Study Group.
229. Schmitz-Valckenberg S., Fleckenstein M., Helb H.M., Charbel Issa P., Scholl H.P., Holz F.G. In vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2009, 50:3915-3921.
230. Schmitz-Valckenberg S., Fleckenstein M., Gobel A.P., Hohman T.C., Holz F.G. Optical coherence tomography and autofluorescence findings in areas with geographic atrophy due to age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2011, 52:1-6.
231. Schroedl F., Brehmer A., Neuhuber W.L., Kruse F.E., May C.A., Cursiefen C. The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) positive macrophages. Invest Ophthalmol. Vis. Sci. 2008, 49:5222-5229.
232. Shen L., Melles R.B., Metlapally R., Barcellos L., Schaefer C., Risch N., Herrinton L.J., Wildsoet C., Jorgenson E. The association of refractive error with glaucoma in a multiethnic population. Ophthalmology 2015, pii: S0161-6420(15)00673-9, [Epub ahead of print]. 10.1016/j.ophtha.2015.07.002.
233. Shinojima A., Kawamura A., Mori R., Yuzawa M. Morphologic features of focal choroidal excavation on spectral domain optical coherence tomography with simultaneous angiography. Retina 2014, 34:1407-1414.
234. Sigler E.J., Randolph J.C. Comparison of macular choroidal thickness among patients older than agew 65 with early atrophic age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 2013, 54:6307-6313.
235. Sivaprasad S., Chong N.V. The complement system and age related macular degeneration. Eye (Lond) 2006, 20:867-872.
236. Sogawa K., Nagaoka T., Takahashi A., Tanano I., Tani T., Ishibazawa A., Yoshida A. Relationship between choroidal thickness and choroidal circulation in healthy young subjects. Am. J. Ophthalmol. 2012, 153:1129-1132.e1.
237. Sohrab M.A., Fawzi A.A. Review of en-face choroidal imaging using spectral-domain optical coherence tomography. Med. Hypothesis Discov. Innov. Ophthalmol. 2013, 2:69-73.
238. Sohrab M., Wu K., Fawzi A.A. A pilot study of morphometric analysis of choroidal vasculature in vivo, using en face optical coherence tomography. PLoS One 2012, 7:e48631.
239. Sonoda S., Sakamoto T., Yamashite T., Otsuka H., Shirasawa M., Kakiuchi N., Uchino E., Terasaki H., Kawano H. Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema. Invest Ophthalmol. Vis. Sci. 2014, 55:3979-3985.
240. Spaide R.F. Enhanced depth-imaging optical coherence tomography of retinal pigment epithelium detachment in age-related macular degeneration. Am. J. Ophthalmol. 2009, 147:644-652.
241. Spaide R.F. Age-related choroidal atrophy. Am. J. Ophthalmol. 2009, 147:801-810.
242. Spaide R.F. Choroidal imaging with optical coherence tomography. Medical Retina Focus on Retinal Imaging 2010, 169-190. Spinger-Verlag, Berlin. F.G. Holz, R.F. Spaide (Eds.).
243. Spaide R.F., Curcio C.A. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 2011, 31:1609-1619.
244. Spaide R.F., Yannuzzi L.A., Slakter J.S., Sorenson J., Orlock D.A. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995, 15:100-110.
245. Spaide R.F., Campeas L., Haas A., et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996, 103:2070-2079.
246. Spaide R.F., Hall L., Haas A., Campeas L., Yannuzzi L.A., Fisher Y.L., Guyer D.R., Slakter J.S., Sorenson J.A., Orlock D.A. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996, 16:203-213.
247. Spaide R.F., Koizumi H., Pozzoni M.C. Enhanced depth imaging spectral-domain optical coherence tomography. Am. J. Ophthalmol. 2008, 146:496-500.
248. Spaide R.F., Fujimoto J.G., Waheed N.K. Image artifacts in optical coherence tomography angiography. Retina 2015, [Epub ahead of print]. 10.1097/IAE.0000000000000765.
249. Spaide R.F., Klancnik J.M., Cooney M.J. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015, 133:45-50.
250. Spaide R.F., Klancnik J.M., Cooney M.J. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomography angiography. JAMA Ophthalmol. 2015, 133:66-73.
251. Srinivasan V.J., Adler D.C., Chen Y., Gorczynska I., Huber R., Duker J.S., Schuman J.S., Fujimoto J.G. Ultrahigh-speed optical coherence tomography for three-dimensional and en face imaging of the retina and optic nerve head. Invest Ophthalmol. Vis. Sci. 2008, 49:5103-5110.
252. Switzer D.W., Mendonca L.S., Saito M., Zweifel S.A., Spaide R.F. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration. Retina 2012, 32:1265-1271.
253. Takamitsu F., Yutaka I., Ron M., Jason S.S., Richard F.S. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am. J. Ophthalmol. 2009, 148:445-450.
254. Tan B.B., Natividad M., Chua K.C., Yip L.W. Comparison of retinal nerve fiber layer measurement between 2 spectral domain OCT instruments. J. Glaucoma 2012, 21:266-273.
255. Tan C.S., Ouyang Y., Ruiz H., Sadda S.R. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol. Vis. Sci. 2012, 53:261-266.
256. Tan C.S., Ngo W.K., Cheong K.X. Comparison of choroidal thickness using swept-source and spectral domain optical coherence tomography in diseased and normal eyes. Br. J. Ophthalmol. 2015, 99:354-358.
257. Tanabe H., Ito Y., Terasaki H. Choroid is thinner in inferior region of optic disks of normal eyes. Retina 2012, 32:134-139.
258. Terasaki H., Miyake Y., Suzuki T., Nakamura M., Nagasaka T. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br. J. Ophthalmol. 2002, 86:321-327.
259. Tian J., Marziliano P., Baskaran M., Tun T.A., Aung T. Automatic segmentation of the choroid in enhanced depth imaging optical coherence tomography images. Biomed. Opt. Express 2013, 4:397-411.
260. Ueda-Arakawa N., Ooto S., Ellabban A.A., Takahashi A., Oishi A., Tamura H., Yamashiro K., Tsujikawa A., Yoshimura N. Macular choroidal thickness and volume of eyes with reticular pseudodrusen using swept-source optical coherence tomography. Am. J. Ophthalmol. 2014, 157:994-1004.
261. Ueno C., Gomi F., Sawa M., Nishida K. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy. Retina 2012, 32:2006-2013.
262. Unterhuber A., Povazay B., Hermann B., Sattmann H., Chavez-Pirson A., Drexler W. In vivo retinal optical coherence tomography at 1040nm - enhanced penetration into the choroid. Opt. Express 2005, 13:3252-3258.
263. Wajer S.D., Taomoto M., McLeod M., McCally R.L., Fabry M.E., Nagel R.L., Lutty G.A. Velocity measurements of normal and sickle red blood cells in the rat retinal and choroidal vasculatures. Microvasc. Res. 2000, 60:281-293.
264. Wang J., Gao X., Huang W., Wang W., Chen S., Li X., Zhang X. Swept-source optical coherence tomography imaging of macular retinal and choroidal structures in healthy eyes. BMC Ophthalmol. 2015, 15:122.
265. Wangsa-Wirawan N.D., Linsenmeier R.A. Retinal oxygen: fundamental and clinical aspects. Arch. Ophthalmol. 2003, 121:547-557.
266. Warrow D.J., Hoang Q.V., Freund K.B. Pachychoroid pigment epitheliopathy. Retina 2013, 33:1659-1672.
267. White B., Pierce M., Nassif N., et al. In vivo dynamic human retinal blood flow imaging using ultra-high-speed spectral domain optical coherence tomography. Opt. Express 2003, 11(25):3490-3497.
268. Whitmore S.S., Sohn E.H., Chirco K.R., Drack A.V., Stone E.M., Tucker B.A., Mullins R.F. Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. Prog. Retin Eye Res. 2015, 45:1-29.
269. Wolter J. Nerves of the human normal choroid. Arch. Ophthalmol. 1960, 64:120.
270. Wood A., Binns A., Margrain T., et al. Retinal and choroidal thickness in early age-related macular degeneration. Am. J. Ophthalmol. 2011, 152:1030-1038.e2.
271. Yamashita T., Shirasawa M., Arimura N., Terasaki H., Sakamoto T. Repeatability and reproducibility of subfoveal choroidal thickness in normal eyes of Japanese using different SD-OCT devices. Invest Ophthalmol. Vis. Sci. 2012, 53:1102-1107.
272. Yamazaki T., Koizumi H., Yamagishi T., Kinoshita S. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12 month results. Ophthalmology 2012, 119:1621-1627.
273. Yannuzzi L.A. Idiopathic polypoidal choroidal vasculopathy. Presented at the Macula Society Meeting; Miami, Florida, USA 1982.
274. Yannuzzi L.A. Central serous chorioretinopathy: a personal perspective. Am. J. Ophthalmol. 2010, 149:361-363.
275. Yannuzzi L.A., Ciardella A., Spaide R.F., Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990, 10:1-8.
276. Yannuzzi L.A., Ciardella A., Spaide R.F., Rabb M., Freund K.B., Orlock D.A. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch. Ophthalmol. 1997, 115:478-485.
277. Yannuzzi L.A., Wong D.W., Sforzolini B.S., Goldbaum M., Tang K.C., Spaide R.F., Freund K.B., Slakter J.S., Guyer D.R., Sorenson J.A., Fisher Y., Maberley D., Orlock D.A. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch. Ophthalmol. 1999, 117:1503-1510.
278. Yannuzzi L.A., Freund K.B., Goldbaum M., Scassellati-Sforzolini B., Guyer D.R., Spaide R.F., Maberley D., Wong D.W., Spakter J.S., Sorenson J.A., Fisher Y.L., Orlock D.A. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000, 107:767-777.
279. Yasuno Y., Miura M., Kawana K., Makita S., Sato M., Akamoto F., Yamanari M., Iwasaki T., Yatagai T., Oshika T. Visualization of sub-retinal pigment epithelium morphologies of exudative macular diseases by high-penetration optical coherence tomography. Invest Ophthalmol. Vis. Sci. 2009, 50:405-413.
280. Yi J., Chen S., Backman V., Zhang H.F. In vivo functional micronagiography by visible-light optical coherence tomography. Biomed. Opt. Express 2014, 5:3603-3612.
281. Yiu G., Manjunath V., Chiu S.J., Farsiu S., Mahmoud T.H. Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema. Am. J. Ophthalmol. 2014, 158:745-751.
282. Zhang H.R. Scanning electron-microscopic study of corrosion casts on retinal and choroidal angioarchitecture in man and animals. Prog. Retin Eye Res. 1994, 13:243-270.
283. Zhang L., Lee K., Niemeijer M., Mullins R.F., Sonka M., Abramoff M.D. Automated segmentation of the choroid from clinical SD-OCT. Invest Ophthalmol. Vis. Sci. 2012, 53:7510-7519.
284. Zhang L., Buitendijk G.H., Lee K., Sonka M., Springelkamp H., Hofman A., Vingerling J.R., Mullins R.F., Klaver C.C., Abramoff M.D. Validity of automated choroidal segmentation in SS-OCT and SD-OCT. Invest Ophthalmol. Vis. Sci. 2015, 56:3202-3211.
285. Zhang L., Buitendijk G.H., Lee K., Sonka M., Springelkamp H., Hofman A., Vingerling J.R., Mullins R.F., Klaver C.C., Abramoff M.D. Validity of automated choroidal segmentation in SS-OCT and SD-OCT. Invest Ophthalmol. Vis. Sci. 2015, 56:3202-3211.
286. Zhang Q., Huang Y., Zhang T., Kubach S., An L., Laron M., Sharma U., Wang R.K. Wide-field imaging of retinal vasculature using optical coherence tomography-based microangiography provided by motion tracking. J. Biomed. Opt. 2015, 20:066008.
287. Zhang Q., Neitz M., Neitz J., Wang R.K. Geographic mapping of choroidal thickness in myopic eyes using 1050-nm spectral domain optical coherence tomography. J. Innov. Opt. Health Sci. 2015, 8:1550012.
288. Zweifel S.A., Imamura Y., Spaide T.C., Fujiwara T., Spaide R.F. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 2010, 117:1775-1781.